Last, we extended these observations to a homologue human tumor context, by staining moderately differentiated (G2) human colon carcinoma sections with anti‐CD8, anti‐PD‐1, and anti‐Drp1‐pSer616 antibodies. Here, CD8A is linked to colon carcinoma.